Norihiro Kokudo

National Center for Global Health and Medicine — Japan

Medicine · Health Sciences

102h-index46.4kcitations1.2kworks2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(456), Liver Disease and Transplantation(233), Organ Transplantation Techniques and Outcomes(229), Cholangiocarcinoma and Gallbladder Cancer Studies(200), Liver Disease Diagnosis and Treatment(199)

Publications1.1k total

Rescue surgery for massive pulmonary thromboembolism due to inferior vena cava tumor thrombus from renal leiomyosarcoma with preoperative veno-arterial extracorporeal membrane oxygenation support: a case report
International Surgery·2026Open Access
Successful Surgical Treatment of Hemosuccus Pancreaticus Caused by Rupture of a Transverse Pancreatic Artery Aneurysm: A Case Report
Surgical Case Reports·2026Open Access
Reply to: “Revisiting Methodologic Paradigms in Local Therapies for Hepatocellular Carcinoma: Insights From the SURF Study” and “Methodologic and Reporting Gaps in the SURF Trial”
Journal of Clinical Oncology·2025
Surgical treatments for early-stage hepatocellular carcinoma: Resection versus transplantation
Global Health & Medicine·2025Open Access
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5
Cell Death and Disease·2025Open Access
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
European Journal of Cancer·2025
122P A machine learning algorithm facilitates treatment selection for up to three hepatocellular carcinomas ≤3 cm in size
ESMO Real World Data and Digital Oncology·2025Open Access
Evaluation of the geographic distribution of patients with hepatocellular carcinoma and treatments in Japan using data from the Japanese national database
Global Health & Medicine·2025Open Access
Protocol of the STRIDE-X study: a multicenter, single-arm trial of single tremelimumab regular interval durvalumab followed by hepatectomy for initially unresectable hepatocellular carcinoma
2025Open Access
1488P Patterns of physical activity (PA) measured by wearable devices during atezolizumab plus bevacizumab combination therapy (Atezo+Bev) in Japanese patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the ELIXIR study
Annals of Oncology·2025
Comparative Study of Laparoscopic Hepatectomy, Open Hepatectomy, and Percutaneous Radiofrequency Ablation for Small Hepatocellular Carcinoma: An Ancillary Study of the SURF Trial
Liver Cancer·2025Open Access
Study on sufficient blood vessel ligation and bowel mobilization in laparoscopic surgery for ascending colon cancer
Global Health & Medicine·2025Open Access
Surgery for postoperative intrahepatic recurrence after curative resection for hepatocellular carcinoma: Repeat hepatectomy versus salvage liver transplantation
Global Health & Medicine·2025Open Access
[Clinical Features and Management of Pseudomyxoma Peritonei Appendiceal Origin].
PubMed·2025
Asia–Pacific modified Delphi consensus conference on large hepatocellular carcinoma
HPB·2025· 2 cited
Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial)
Journal of Clinical Oncology·2025· 9 cited
A Newly Launched Nationwide Database Revealed Real-world Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)
Liver Cancer·2025· 5 citedOpen Access
Expanding the horizons of cytoreductive surgery-hyperthermic intraperitoneal chemotherapy and liver resection for colorectal peritoneal and liver metastases
HepatoBiliary Surgery and Nutrition·2025Open Access
Combined hepatocellular cholangiocarcinoma: A population-based retrospective study.
Journal of Clinical Oncology·2025
A multicenter prospective study to evaluate the efficacy of resection for initially unresectable hepatocellular carcinoma after atezolizumab combined with bevacizumab (the RACB study).
Journal of Clinical Oncology·2025
page 1 of 58Next →

Frequent Co-authors

Kiyoshi Hasegawa(18), Masatoshi Makuuchi(13), Masatoshi Kudo(12), Yutaka Matsuyama(12), Namiki Izumi(11), Tadatoshi Takayama(11), Takeaki Ishizawa(9), Michiie Sakamoto(7), Osamu Nakashima(7), Taku Aoki(6), Ryosuke Tateishi(5), Shoji Kubo(5), Shuichi Kaneko(5), Shinji Üemoto(5), Yoshihiro Sakamoto(5), Go Wakabayashi(4), Brice Gayet(4), Junji Shibahara(4), Masashi Fukayama(4), Osamu Matsui(4)